SPINAL MYOCLONUS - SUCCESSFUL TREATMENT WITH THE COMBINATION OF SODIUM VALPROATE AND L-5-HYDROXYTRYPTOPHAN

被引：4
|
作者：
JIMENEZJIMENEZ, FJ
ROLDAN, A
ZANCADA, F
MOLINAARJONA, JA
FERNANDEZBALLESTEROS, A
SANTOS, J
机构：
[1] HOSP NA SRA,UNIDAD NEUROL,CACERES,SPAIN
[2] HOSP NA SRA,SERV MED INTERNA,CACERES,SPAIN
来源：
CLINICAL NEUROPHARMACOLOGY | 1991年 / 14卷 / 02期
关键词：
MYOCLONUS; SEGMENTAL MYOCLONUS; SPINAL MYOCLONUS; SODIUM VALPROATE; L-5-HYDROXYTRYPTOPHAN; SEROTONERGIC PATHWAYS;
D O I：
10.1097/00002826-199104000-00009
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We describe a 37-year-old man with spinal segmental myoclonus characterized by symmetric, rhythmic contractions of the abdomen with a frequency ranging between 100 and 150/min. The combination of sodium valproate and L-5-hydroxytryptophan was useful to control the myoclonus. We comment on the possible role of the serotonergic system in this syndrome.
引用
收藏
页码：186 / 190
页数：5
相关论文
共 50 条
  • [21] LACK OF SUPERSENSITIVITY TO L-5-HYDROXYTRYPTOPHAN FOLLOWING CHRONIC METHYSERGIDE TREATMENT
    TRULSON, ME
    STARK, AD
    JACOBS, BL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) : 382 - 384
  • [22] SUCCESSFUL TREATMENT OF ACTION MYOCLONUS WITH 5-HYDROXYTRYPTOPHAN IN CHERRY RED SPOT - MYOCLONUS SYNDROME
    GASCON, G
    WALLENBERG, B
    DAIF, AK
    OZAND, P
    ANNALS OF NEUROLOGY, 1986, 20 (03) : 440 - 440
  • [23] EFFECT OF L-CYSTEINE ON THE OXIDATION OF L-5-HYDROXYTRYPTOPHAN
    WU, Z
    DRYHURST, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 20 - ANYL
  • [24] BACKWARD WALKING INDUCED BY L-5-HYDROXYTRYPTOPHAN IN MICE
    SHIMOMURA, K
    MORI, J
    HONDA, F
    JAPANESE JOURNAL OF PHARMACOLOGY, 1981, 31 (01): : 39 - 46
  • [25] SUCCESSFUL TREATMENT OF CHERRY RED SPOT MYOCLONUS SYNDROME WITH 5-HYDROXYTRYPTOPHAN
    GASCON, G
    WALLENBERG, B
    DAIF, AK
    OZAND, P
    ANNALS OF NEUROLOGY, 1988, 24 (03) : 453 - 455
  • [26] L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI
    Lowe, SL
    Yeo, KP
    Teng, LY
    Soon, DKW
    Pan, A
    Wise, SD
    Peck, RW
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (04) : 473 - 484
  • [27] RAPHE NEURONS - DEPRESSION OF ACTIVITY BY L-5-HYDROXYTRYPTOPHAN
    TRULSON, ME
    JACOBS, BL
    BRAIN RESEARCH, 1975, 97 (02) : 350 - 355
  • [28] KINETICS OF L-5-HYDROXYTRYPTOPHAN IN HEALTHY-SUBJECTS
    WESTENBERG, HGM
    GERRITSEN, TW
    MEIJER, BA
    VANPRAAG, HM
    PSYCHIATRY RESEARCH, 1982, 7 (03) : 373 - 385
  • [29] PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED L-5-HYDROXYTRYPTOPHAN IN MAN
    MAGNUSSEN, I
    NIELSENKUDSK, F
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1979, 44 (04): : 308 - 314
  • [30] EFFECTS OF L-5-HYDROXYTRYPTOPHAN IN AUTISTIC-CHILDREN
    SVERD, J
    KUPIETZ, SS
    WINSBERG, BG
    HURWIC, MJ
    BECKER, L
    JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1978, 8 (02): : 171 - 180
12345